Peyrou V[au] - Search Results

Year	Number of Results
1994	1
1997	2
1998	1
1999	1
2001	1
2002	1
2003	1
2006	2
2012	1
2024	0

1

Contribution of erythrocytes to thrombin generation in whole blood.

Peyrou V, Lormeau JC, Hérault JP, Gaich C, Pfliegger AM, Herbert JM. Peyrou V, et al. Thromb Haemost. 1999 Mar;81(3):400-6. Thromb Haemost. 1999. PMID: 10102469

2

Synthesis and trichomonacidal activity of perketals and hydroperoxides.

Cointeaux L, Berrien JF, Camuzat-Dedenis B, Peyrou V, Provot O, Bories C, Loiseau PM, Mayrargue J. Cointeaux L, et al. Among authors: peyrou v. Farmaco. 2002 Jun;57(6):457-62. doi: 10.1016/s0014-827x(02)01238-7. Farmaco. 2002. PMID: 12088060

3

From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.

Barth M, Bondoux M, Luccarini JM, Peyrou V, Dodey P, Pruneau D, Massardier C, Paquet JL. Barth M, et al. Among authors: peyrou v. J Med Chem. 2012 Mar 22;55(6):2574-84. doi: 10.1021/jm2016057. Epub 2012 Mar 6. J Med Chem. 2012. PMID: 22369198

4

Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist.

Porreca F, Vanderah TW, Guo W, Barth M, Dodey P, Peyrou V, Luccarini JM, Junien JL, Pruneau D. Porreca F, et al. Among authors: peyrou v. J Pharmacol Exp Ther. 2006 Jul;318(1):195-205. doi: 10.1124/jpet.105.098368. Epub 2006 Mar 24. J Pharmacol Exp Ther. 2006. PMID: 16565167

5

Pharmacological properties of CY 216 and of its ACLM and BCLM components in the rabbit.

Peyrou V, Lormeau JC, Caranobe C, Gabaig AM, Crepon B, Saivin S, Houin G, Sié P, Boneu B. Peyrou V, et al. Thromb Haemost. 1994 Aug;72(2):268-74. Thromb Haemost. 1994. PMID: 7831664

6

Synthesis, structures, and magnetic properties of tetranuclear CuII-LnIII complexes.

Costes JP, Auchel M, Dahan F, Peyrou V, Shova S, Wernsdorfer W. Costes JP, et al. Among authors: peyrou v. Inorg Chem. 2006 Mar 6;45(5):1924-34. doi: 10.1021/ic050587o. Inorg Chem. 2006. PMID: 16499353

7

Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.

Herault JP, Peyrou V, Savi P, Bernat A, Herbert JM. Herault JP, et al. Among authors: peyrou v. Thromb Haemost. 1998 Feb;79(2):383-8. Thromb Haemost. 1998. PMID: 9493595

8

Long-term persistence of low-molecular-weight material with anti-factor Xa activity contributes to anticoagulant and antithrombotic effects after subcutaneous injection of CY 216 in the rabbit.

Peyrou V, Lormeau JC, Hérault JP, Boneu B, Herbert JM. Peyrou V, et al. Blood Coagul Fibrinolysis. 1997 Apr;8(3):175-84. doi: 10.1097/00001721-199704000-00004. Blood Coagul Fibrinolysis. 1997. PMID: 9167018

9

The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.

Peyrou V, Béguin S, Boneu B, Hemker HC. Peyrou V, et al. Thromb Haemost. 1997 Feb;77(2):312-6. Thromb Haemost. 1997. PMID: 9157588

10

Synthesis and in vitro Trichomonacidal activities of some new dialkylperoxides and 1,2,4-trioxanes.

Camuzat-Dedenis B, Provot O, Cointeaux L, Peyrou V, Berrien JF, Bories C, Loiseau PM, Mayrargue J. Camuzat-Dedenis B, et al. Among authors: peyrou v. Eur J Med Chem. 2001 Oct;36(10):837-42. doi: 10.1016/s0223-5234(01)01278-8. Eur J Med Chem. 2001. PMID: 11738490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year